MEDP — Medpace Holdings, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1668397 ·
Last close
$466.79
Market Cap
$13.33B
52W High
$530.97
52W Low
$373.00
ADV30
331,269
Next earnings
2026-07-20
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 706,604,000 | 196,326,000 | 141,503,000 | 123,870,000 | 2,129,613,000 | 652,681,000 | 1,531,299,000 |
| Dec 2025 | 708,450,000 | 205,316,000 | 153,269,000 | 135,133,000 | 1,975,472,000 | 497,049,000 | 1,516,401,000 |
| Sep 2025 | 659,903,000 | 196,939,000 | 141,808,000 | 111,135,000 | 1,753,012,000 | 285,351,000 | 1,459,371,000 |
| Jun 2025 | 603,311,000 | 180,013,000 | 126,335,000 | 90,260,000 | 1,571,673,000 | 46,330,000 | 1,399,322,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$739,175,000
Investing CF
$-27,901,000
Financing CF
$-501,752,000
CapEx
$-28,176,000
Dividends Paid
—
Buybacks
$-545,489,000
EPS Diluted TTM
$15.91
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-336,111,000
Inventory
—
Receivables
$394,581,000
ST Investments
—
EBIT TTM
$562,915,000
Pretax Income TTM
$571,798,000
Interest Exp TTM
—
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,678,267,904
EBITDA
$591,014,976
Free Cash Flow
$490,738,880
Enterprise Value
$12,824,790,016
Total Cash
$652,681,024
Total Debt
$146,094,000
Shares Out
28,559,689
Trailing EPS
$15.91
Book Value
$20.95
ROE
77.3%
ROA
17.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,530,234,000 | 534,935,000 | 451,123,000 | 1,975,472,000 | 1,516,401,000 | — | 713,223,000 |
| Dec 2024 | 2,109,054,000 | 446,870,000 | 404,386,000 | 2,100,866,000 | 1,275,321,000 | — | 608,815,000 |
| Dec 2023 | 1,885,842,000 | 336,825,000 | 282,810,000 | 1,656,828,000 | 1,097,878,000 | — | 433,374,000 |
| Dec 2022 | 1,459,996,000 | 278,697,000 | 245,368,000 | 1,352,495,000 | 966,108,000 | — | 388,050,000 |
TTM Snapshot
Revenues TTM
$1,705,127,000
NetIncome TTM
$281,577,000
OpCashFlow TTM
$0
Assets (Latest)
$2,100,866,000
Forward EPS
$18.56
Max Pain — expiry 2026-12-18
max pain strike: $570.00 · spot: $466.79 · call oi: 129 · put oi: 2,049
Expected Move to 2026-12-18:
±$146.43
(31.37%) —
implied range
$320.36 –
$613.22
· ATM straddle on $470.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ICLR | ICON PLC | $11.62B | $151.82 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $9.14B | $189.85 | — |
| INCY | INCYTE CORP | $20.62B | $103.23 | — |
| LNTH | Lantheus Holdings, Inc. | $6.51B | $99.98 | — |
| IQV | IQVIA HOLDINGS INC. | $31.09B | $186.25 | — |
News headlines (Yahoo Finance, 1h cache)
Why the Market Dipped But Medpace (MEDP) Gained Today
2026-06-09 22:15 · Yahoo
How Investors May Respond To Medpace (MEDP) Lawsuits And EVP Shift In Operating Leadership
2026-06-06 01:05 · Yahoo
3 Cash-Producing Stocks with Promising Prospects
2026-06-04 20:37 · Yahoo
Congressman Looking For Dividends? Taylor Ditches 2 Magnificent Seven Stocks For Blue Chips
2026-06-03 09:46 · Yahoo
Medpace (MEDP) Stock Slides as Market Rises: Facts to Know Before You Trade
2026-06-02 22:15 · Yahoo
LH or MEDP: Which Is the Better Value Stock Right Now?
2026-05-27 15:40 · Yahoo
2 Reasons to Watch MEDP and 1 to Stay Cautious
2026-05-17 23:16 · Yahoo
Medpace Class Actions Put Backlog Disclosures And Governance In Spotlight
2026-05-15 11:12 · Yahoo
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
2026-05-14 16:36 · Yahoo
PACS vs. MEDP: Which Stock Is the Better Value Option?
2026-05-11 15:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.